Current Research Status of Pathogenesis, Diagnosis and Treatment of Inflammatory Bowel Disease: MiRNAs With Intestinal Immunity and Barrier Function
10.3969/j.issn.1008-7125.2020.11.010
- Author:
Baoyue LI
1
;
Xiangdian BU
1
;
Wenxuan CHEN
1
;
Na MA
1
;
Muhan ZHANG
1
;
Baisui FENG
1
Author Information
1. Department of Gastroenterology, The Second Affiliated Hospital of Zhengzhou University
- Publication Type:Journal Article
- Keywords:
Immunocyte;
Inflammatory Bowel Disease;
Intestinal Mucosal Barrier;
MicroRNAs;
Proinflammatory Cytokines
- From:Chinese Journal of Gastroenterology
2020;25(11):687-691
- CountryChina
- Language:Chinese
-
Abstract:
MicroRNAs (miRNAs) are a group of short non-coding RNAs consisting of about 22 nucleotides that downregulate gene expression at posttranscriptional level through binding to the 3'-untranslated region (3'-UTR) of target mRNAs. With the increase in research about miRNAs, it is found that miRNAs could modulate the differentiation and secretion of immunocytes as well as the function of intestinal mucosal barrier. Besides, miRNAs could regulate the composition of intestinal microbiome, and could be used as crucial biomarkers for the diagnosis of inflammatory bowel disease (IBD). In this paper, the roles of miRNAs in the pathogenesis of IBD were reviewed through intestinal immunity and barrier function.
